Theratechnologies Inc T.TH

Short interest on THTX plummets

[SPCEO1]

Following the offering, short interest on THTX fell by 2.1 million shares to just short of 350,000 shares, which is a miniscule amount of shorts. Those shorts were no doubt covered in the deal. Short interest was quite low before but now is almost non-existent in THTX shares.

[jeffm34]

So now just 10-12M more shares to get through that keep coming up for sale as soon as the share price gets above the offering price. 

[SPCEO1]

So, wht you seem to be suggesting is that those who participated in the offering did so to make a few pennies and then move on? That would be quite odd, don't you think?

[jeffm34]

It's a free ride with the warrants.  Sell the shares as soon as they are profitable and you still have lots of risk free upside with the warrants. 

[SPCEO1]

Some certainly are going to do that, or already have done that, but I really don't think all 16.7 million new shares are likely to be sellers as soon as the stock hits $2.75 (or $2.50 depending on how or if you want to incorporate a value for the warrants). 

[jeffm34]

you do if you think there is nothing to move the share price in the short or medium term.  All we have for the rest of 2021 is product sales to go on.  Oncology data won't start coming out until next year.  The confirmation of an already announced phase 3 NASH trial isn't going to move anything 

[SPCEO1]

No oncology data until next year???? I am not sure why you think that. The trial is to start in the second quarter and since it is open label, we can expect to hear about any good news close to when the company discovers it. So, there shoould be quite a lot of important, likely market moving, cancer news this year. Moreover, I suspect the larger institutions in the deal were likely in it more for

[qwerty22]

Here's ten things I think we might find out about the drug over the  course of Ph1 and the very rough timeframe I think we might get some indication. The final group are things that aren't fixed into the Ph1 process and so may come  Ph1, Ph2 or never. Early Ph1 (late 2021) 1) Dose 2) Initial safety signals 3) Initial efficacy signal 4) Size of human therapeutic window

[SPCEO1]

I am curious why you think it will be late 2021 before we get the first feedback from the phase I cancer trial. The trial could start in April. If it did, the dose escalation portion fo the trial would be done by summer, I would think. Do you think the company would make any comment if they saw promising results after even the first two dose escalation patients - ie. no safety issues and some

[scarlet1967]

I agree the CEO said they will be trying to accelerate the programs, they have now Fast track designation, Leah said behind closed doors the tram are working hard to produce results she also mentioned the CMO and CEO among others are working overtime so I rather go with what they say than any predictions here.

[jeffm34]

It will be several months before the first patient is dosed. It will be another few months to determine what the response was. Then you have to determine whether that response was greater than in patients who received just the chemo drug alone.  That is not a quick process.  Unless there is overwhelming evidence the drug peptide combination is far superior to anything else out there we

[jfm1330]

I think you missed something about patient selection for this trial. Study Description   Go to   Brief Summary: Open label first-in-human study of TH1902 in solid cancer, with 2 sequential parts: Part 1 (dose escalation): patients with recurrent advanced solid tumors (all comers) that have relapsed or are refractory to standard chemotherapy,

[jeffm34]

They will not start releasing results from single patient data.  So what happens if they release data from a single patient that suggests a great response and the price sky rockets.  Then the final analysis comes that can't show any statistical significance or unmanageable side effects in the majority of patients.  They will spend the next 5 years dealing with class action

[Bucknelly21]

What are you doing? trying to hold this forever? If it skyrocketed then sell! The one thing about jfm I'm confused about is what is your exit plan?

[scarlet1967]

Wrong again so you are suggesting all other companies who release early data getting sued because the trial fails at the end?'well go and search the success rate for each of stages for trials none of them is 100 percent.

[palinc2000]

A few pennies,,,,,Nope ..I have posted many many times before but somehow you dont seem to understand,,,,They get warrants at no cost and no risks,,,,FOR 3 YEARS and get the right to buy at 3.18$ ,,,,How many of the 16 million shares  holders will do that? IDK but I expect at least 6 million shares,,,,Just look at the trading ,,,,Sellers keep hitting the bid multiple times during the day

[scarlet1967]

As per Leah those shares are owned by institutions and they will report their holdings in May so we can see who they are on SEC. I would like to also remind you she and the company is reading our post as the day I posted my understanding of our phone call she read my post and emailed me later that night to clarify the regular guidance which was one of many things we discussed, note she didn't

[palinc2000]

I am very anxious to see what portion of the 16 million units have been sold to long term holders,,,,,BTW she did refuse to confirm the amount during your call,,

[scarlet1967]

Yes she said it's not public information.